Cosomil, Inc.

Private

TokyoHealthcare & Life Scienceshttps://cosomil.com/

Last Round

Series A

Extension

Feb 6, 2026

Total Funding Raised

$3.31M

Company Overview

Cosomil, Inc. is a biotechnology company that develops high-precision liquid biopsy diagnostic technologies for the early detection of cancer and drug development support.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

liquid biopsysingle-molecule enzyme activity-based protein profilingSEAPearly cancer detectionbiotech startupprecision medicinedrug discoverybiomarker discoverydiagnostic platformoncology diagnosticscontract researchmicrofluidicsnext-gen diagnosticsdeep tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cosomil, Inc. Comps

Public and private peers based on sector, stage, and business model.

Cosomil, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cosomil, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Feb 6, 2026
Grant	Mar 22, 2024
Early Funding	Nov 29, 2023
Pre Seed	Apr 1, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Yu Kagami

CEO

Executive Team

Cosomil, Inc. Investors

Notable investors and investment history

Cosomil, Inc. investors
Investor	Rounds
New Energy and Industrial Technology Development Organization	Grant
ANRI株式会社	Series A Extension, Early Funding
Delight Ventures	Series A Extension
Coral Capital	Early Funding

View all Investors

Cosomil, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cosomil, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cosomil, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo

Employee Range4

Year Founded2022

Last FundingFeb 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.